The company
Eupraxia Pharmaceuticals Inc.
EPRX · Nasdaq
EPRX stood above a rising 150-day average in 28 of the last 52 weekly readings, and has been out of that trend for the last 23 weeks. It is 9.8% above that average now. Biotechnology: 18% of its 561 stocks in an uptrend (−12 points in four weeks); Health Care: 28% (−6 points in four weeks).
Statistics
- Rotation
- Above a falling average
- Weeks in an uptrend
- out for 23
- Industry in uptrend
- 18% -12 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 0
- Institutions holding
- 66 (+15)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 28 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
No open-market buy or sale by its insiders on record.
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| Affinity Asset Advisors, LLCadded · filed 13 Aug 2026 | 1,650,000$10.9M | +60,995+3.8% |
| Balyasny Asset Management L.P.added · filed 14 Aug 2026 | 1,350,015$8.9M | +150.0% |
| Vivo Capital, LLCunchanged · filed 14 Aug 2026 | 1,350,000$8.9M | 00.0% |
| SCOTIA CAPITAL INC.added · filed 11 Aug 2026 | 1,343,726$8.8M | +1,548+0.1% |
| PFM Health Sciences, LPadded · filed 14 Aug 2026 | 1,210,661$8.0M | +669,790+123.8% |
| GREAT POINT PARTNERS LLCunchanged · filed 14 Aug 2026 | 1,200,000$7.9M | 00.0% |
| Jupiter Topco LLCnew · filed 14 Aug 2026 | 1,046,000$6.9M | +1,046,000 |
| Rubric Capital Management LPadded · filed 14 Aug 2026 | 867,424$5.7M | +176,254+25.5% |
| Ikarian Capital, LLCreduced · filed 14 Aug 2026 | 809,741$5.4M | -405,000−33.3% |
| Woodline Partners LPadded · filed 14 Aug 2026 | 746,864$4.9M | +306,313+69.5% |
News
Everyone who traded it
Nobody on record has traded it.
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.